Advertisement

What Is the Outcome of Atrial Fibrillation Ablation in Patients with Left Ventricular Dysfunction?

  • L. -F. Hsu
  • P. Sanders
  • M. Hocini
  • F. Sacher
  • M. Rotter
  • Y. Takahashi
  • T. Rostock
  • C. Scavée
  • M. Haïssaguerre
  • P. JAïs

Keywords

Atrial Fibrillation Sinus Rhythm Catheter Ablation Antiarrhythmic Drug Persistent Atrial Fibrillation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stevenson WG, Stevenson LW (1999) Atrial fibrillation in heart failure. N Engl J Med 341:910–911PubMedCrossRefGoogle Scholar
  2. 2.
    Ehrlich JR, Nattel S, Hohnloser SH (2002) Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. J Cardiovasc Electrophysiol 13:399–405PubMedCrossRefGoogle Scholar
  3. 3.
    Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 84:40–48PubMedGoogle Scholar
  4. 4.
    Wang TJ, Larson MG, Levy D et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920–2925PubMedCrossRefGoogle Scholar
  5. 5.
    Shinbane JS, Wood MA, Jensen DN et al (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29:709–715PubMedCrossRefGoogle Scholar
  6. 6.
    Natale A, Zimerman L, Tomassoni G et al (1996) Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 78:1431–1433PubMedCrossRefGoogle Scholar
  7. 7.
    Clark DM, Plumb VJ, Epstein AE et al (1997) Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 30:1039–1045PubMedCrossRefGoogle Scholar
  8. 8.
    Daoud EG, Weiss R, Bahu M et al (1996) Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 78:1433–1436PubMedCrossRefGoogle Scholar
  9. 9.
    Falk RH (2001) Atrial fibrillation. N Engl J Med 344:1067–1078PubMedCrossRefGoogle Scholar
  10. 10.
    The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833CrossRefGoogle Scholar
  11. 11.
    Van Gelder IC, Hagens VE, Bosker HA et al (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840PubMedCrossRefGoogle Scholar
  12. 12.
    Hohnloser SH, Kuck KH et al (2000) Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomized trial. Lancet 356:1789–1794PubMedCrossRefGoogle Scholar
  13. 13.
    Corley SD, Epstein AE, DiMarco JP et al (2004) Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation109:1509–1513PubMedCrossRefGoogle Scholar
  14. 14.
    Hagens VE, Van Veldhuisen DJ, Kamp O et al (2005) Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the Rate Control versus Electrical Cardioversion for persistent atrial fibrillation (RACE) study. Heart Rhythm 2:19–24PubMedCrossRefGoogle Scholar
  15. 15.
    Wood MA, Brown-Mahoney C, Kay GN et al (2000) Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation 101:1138–1144PubMedGoogle Scholar
  16. 16.
    Brignole M, Menozzi C, Gianfranchi L et al (1998) Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized controlled study. Circulation 98:953–960PubMedGoogle Scholar
  17. 17.
    Ozcan C, Jahangir A, Friedman PA et al (2003) Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction. Am J Cardiol 92:33–37PubMedCrossRefGoogle Scholar
  18. 18.
    Doshi R, Daoud E, Fellows C et al (2004) PAVE: the first prospective randomized study evaluating biventricular pacing after ablate and pace therapy. Presented at the American College of Cardiology Annual Scientific Session 2004, March 7–10, New Orleans, LAGoogle Scholar
  19. 19.
    Brignole M, Gammage M, Puggioni E et al on behalf of the Optimal Pacing Site (Opsite) Study Investigators (2005) Comparative assessment of right, left and biventricular pacing in patients with permanent atrial fibrillation. Eur Heart J:26:712–722PubMedCrossRefGoogle Scholar
  20. 20.
    Cappato R, Calkins H, Chen SA et al (2005) Worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100–1115PubMedCrossRefGoogle Scholar
  21. 21.
    Chen MS, Marrouche NF, Khaykin Y et al (2004) Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 43:1004–1009PubMedCrossRefGoogle Scholar
  22. 22.
    Hsu LF, Jaïs P, Sanders P et al (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383PubMedCrossRefGoogle Scholar
  23. 23.
    Pappone C, Augello G, Vicedomini G et al (2003) Circumferential pulmonary vein ablation in patients with atrial fibrillation and associated systolic or diastolic heart failure. Eur Heart J 24:494 (abs)CrossRefGoogle Scholar
  24. 24.
    Cha YM, Asirvatham SJ, Friedman PA et al (2004) Improvement in left ventricular function following radiofrequency catheter ablation of atrial fibrillation in patients with congestive heart failure. Heart Rhythm 1:S139 (abs)CrossRefGoogle Scholar
  25. 25.
    Gentlesk P, Sauer WH, Zado ES et al (2004) Ablation of atrial fibrillation in patients with decreased ejection fraction: outcome and evidence for reversible cardiomyopathy. Heart Rhythm 1:S171–S172 (abs)Google Scholar
  26. 26.
    Pappone C, Rosanio S, Augello G et al (2003) Mortality, morbidity and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled, nonrandomized long-term study. J Am Coll Cardiol 42:185–197PubMedCrossRefGoogle Scholar
  27. 27.
    De Ferrari GM, Petracci B, Frattini F et al (2005) Long-term effects of an aggressive rhythm control strategy in patients with permanent atrial fibrillation and advanced heart failure. Heart Rhythm 2:S116 (abs)CrossRefGoogle Scholar
  28. 28.
    Stevenson WG, Stevenson LW (2004) Atrial fibrillation and heart failure — five more years. N Engl J Med 351:2437–2440PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • L. -F. Hsu
    • 1
  • P. Sanders
    • 2
  • M. Hocini
    • 2
  • F. Sacher
    • 2
  • M. Rotter
    • 2
  • Y. Takahashi
    • 2
  • T. Rostock
    • 2
  • C. Scavée
    • 2
  • M. Haïssaguerre
    • 2
  • P. JAïs
    • 2
  1. 1.National Heart CentreSingapore
  2. 2.Hôital Cardiologique du Haut-LévêueBordeaux-PessacFrance

Personalised recommendations